• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项关于每周口服甲氨蝶呤对肝脏活检影响的前瞻性研究。

A prospective study of the effects of weekly oral methotrexate on liver biopsy.

作者信息

Warin A P, Landells J W, Levene G M, Baker H

出版信息

Br J Dermatol. 1975 Sep;93(3):321-7. doi: 10.1111/j.1365-2133.1975.tb06498.x.

DOI:10.1111/j.1365-2133.1975.tb06498.x
PMID:1103936
Abstract

The results are reported of a prospective study of liver histological findings in twenty-five patients with severe psoriasis subjected to liver biopsy before and at intervals after the onset of treatment with methotrexate by an intermittent dosage schedule. The pre-methotrexate liver biopsy findings in forty-one other severe psoriatics are also summarized. Of the twenty-five treated patients, four showed a mild inflammatory cell infiltrate and two mild fibrosis before treatment. During treatment only one developed a grade 2 infiltrate and one other grade 2 fibrosis. None has developed cirrhosis. Where minor abnormalities developed, their fluctuating and reversible nature is demonstrated.

摘要

报告了一项前瞻性研究的结果,该研究针对25例重度银屑病患者,在采用间歇给药方案进行甲氨蝶呤治疗之前及治疗开始后的不同时间间隔进行了肝脏活检,以观察肝脏组织学变化。同时也总结了另外41例重度银屑病患者在使用甲氨蝶呤治疗前的肝脏活检结果。在接受治疗的25例患者中,4例在治疗前显示轻度炎性细胞浸润,2例有轻度纤维化。治疗期间,仅1例出现2级浸润,另1例出现2级纤维化。无人发展为肝硬化。对于出现的轻微异常,研究证实了其波动及可逆的特性。

相似文献

1
A prospective study of the effects of weekly oral methotrexate on liver biopsy.一项关于每周口服甲氨蝶呤对肝脏活检影响的前瞻性研究。
Br J Dermatol. 1975 Sep;93(3):321-7. doi: 10.1111/j.1365-2133.1975.tb06498.x.
2
Liver biopsies in psoriatics--complications and evaluation.
Int J Dermatol. 1980 May;19(4):217-9. doi: 10.1111/j.1365-4362.1980.tb00302.x.
3
Liver biopsy in methotrexate-treated psoriatics-a re-evalution.甲氨蝶呤治疗银屑病患者的肝脏活检——重新评估
Acta Derm Venereol. 1975;55(4):291-6.
4
Low incidence of hepatotoxicity associated with long-term, low-dose oral methotrexate in treatment of refractory psoriasis, psoriatic arthritis, and rheumatoid arthritis. An acceptable risk/benefit ratio.长期低剂量口服甲氨蝶呤治疗难治性银屑病、银屑病关节炎和类风湿关节炎时肝毒性发生率低。风险/效益比可接受。
Dig Dis Sci. 1985 Feb;30(2):104-9. doi: 10.1007/BF01308193.
5
Sequential liver biopsies during long-term methotrexate treatment for psoriasis: a reappraisal.长期使用甲氨蝶呤治疗银屑病期间的序贯肝活检:重新评估
Br J Dermatol. 1995 Nov;133(5):774-8. doi: 10.1111/j.1365-2133.1995.tb02754.x.
6
Effects of methotrexate on the liver in psoriasis.甲氨蝶呤对银屑病肝脏的影响。
J Invest Dermatol. 1974 Jun;62(6):597-602. doi: 10.1111/1523-1747.ep12679887.
7
Methotrexate induced liver disease in psoriasis.
Br J Dermatol. 1974 Jun;90(6):661-7. doi: 10.1111/j.1365-2133.1974.tb06695.x.
8
Liver biopsies from psoriatics treated with methotrexate.接受甲氨蝶呤治疗的银屑病患者的肝脏活检样本。
Ann Acad Med Singap. 1986 Apr;15(2):210-4.
9
Methotrexate hepatotoxicity in psoriasis--comparison of different dose regimens.银屑病中甲氨蝶呤的肝毒性——不同剂量方案的比较
Br Med J. 1972 Mar 11;1(5801):654-6. doi: 10.1136/bmj.1.5801.654.
10
[Incidence of liver diseases in psoriatic patients with special reference to methotrexate therapy].[银屑病患者肝脏疾病的发病率,特别提及甲氨蝶呤治疗]
Dermatol Monatsschr. 1973 Mar;159(3):242-8.

引用本文的文献

1
Psoriasis. A review of recent advances in treatment.银屑病。治疗新进展综述。
Drugs. 1984 Oct;28(4):324-46. doi: 10.2165/00003495-198428040-00003.
2
Low incidence of hepatotoxicity associated with long-term, low-dose oral methotrexate in treatment of refractory psoriasis, psoriatic arthritis, and rheumatoid arthritis. An acceptable risk/benefit ratio.长期低剂量口服甲氨蝶呤治疗难治性银屑病、银屑病关节炎和类风湿关节炎时肝毒性发生率低。风险/效益比可接受。
Dig Dis Sci. 1985 Feb;30(2):104-9. doi: 10.1007/BF01308193.
3
Oral methotrexate.口服甲氨蝶呤。
Dig Dis Sci. 1986 Apr;31(4):443-5. doi: 10.1007/BF01311685.
4
Low dose pulse methotrexate in rheumatoid arthritis: an 8-year experience with hepatotoxicity.低剂量脉冲甲氨蝶呤治疗类风湿关节炎:8年肝毒性经验
Clin Rheumatol. 1987 Dec;6(4):575-82. doi: 10.1007/BF02330596.
5
Hepatotoxicity of methotrexate in rheumatic diseases.甲氨蝶呤在风湿性疾病中的肝毒性。
Med Toxicol Adverse Drug Exp. 1988 May-Jun;3(3):197-208. doi: 10.1007/BF03259882.
6
Liver histology in patients receiving low dose pulse methotrexate for the treatment of rheumatoid arthritis.接受低剂量脉冲甲氨蝶呤治疗类风湿关节炎患者的肝脏组织学
Ann Rheum Dis. 1990 Aug;49(8):591-3. doi: 10.1136/ard.49.8.591.
7
Histopathological effects of methotrexate on mouse liver.甲氨蝶呤对小鼠肝脏的组织病理学影响。
Br J Exp Pathol. 1978 Jun;59(3):327-31.
8
Pathology of folate deficiency.叶酸缺乏的病理学
Proc R Soc Med. 1977 Feb;70(2):82-4. doi: 10.1177/003591577707000206.